Related Experiment Video
Updated: Apr 17, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
The correlation between hepatitis C core antigen and hepatitis C virus RNA levels with respect to human
Vo Duy Thong1, Srunthron Akkarathamrongsin, Anchalee Avihingsanon
1Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Insights
Serum hepatitis C virus core antigen (HCVcAg) levels strongly correlate with HCV RNA, especially in coinfected patients. This HCV marker may be useful in resource-limited settings.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Serum hepatitis C virus core antigen (HCVcAg) correlates with HCV RNA in monoinfected individuals.
- Limited data exist on HCVcAg in HCV/HIV coinfected patients.
Purpose of the Study:
- To compare HCVcAg measurement against HIV status, HCV genotypes, IFNL4 polymorphism, and clinical parameters.
- To evaluate HCVcAg as a potential alternative to HCV RNA assays.
Main Methods:
- Analysis of an untreated cohort: 104 HCV monoinfected and 85 HCV/HIV coinfected patients.
- Serum HCVcAg measured via chemiluminescent microparticle immunoassay.
- IFNL4 polymorphism ss469415590 identified by real-time PCR.
Main Results:
- HCVcAg strongly correlated with HCV RNA (r = 0.889, p < 0.001), particularly in coinfected patients.
- Mean HCVcAg was higher in coinfected vs. monoinfected patients.
- HCVcAg levels associated with IFNL4 TT/TT genotype but not ALT or liver stiffness.
Conclusions:
- HCVcAg shows excellent correlation with HCV RNA, especially in HCV/HIV coinfection.
- HCVcAg may be influenced by IFNL4 polymorphism.
- HCVcAg testing offers a potential alternative to HCV RNA assays in resource-limited settings.
Objectives:
Serum hepatitis C virus (HCV) core antigen (HCVcAg) concentrations correlate with HCV RNA levels in HCV monoinfected patients. Data in HCV/HIV coinfected patients are still limited. We aim to compare the use of HCVcAg measurement with respect to HIV status, HCV genotypes, interferon-lambda-4 (IFNL4) polymorphism and clinical parameters.
Methods:
We analyzed an untreated cohort of 104 patients with HCV monoinfection and 85 patients with HCV/HIV coinfection. Serum HCVcAg was measured by a commercial chemiluminescent microparticle immunoassay. The presence of IFNL4 polymorphism ss469415590 was identified by real-time PCR.
Results:
log10 HCVcAg levels were significantly correlated with corresponding log10 HCV RNA levels (r = 0.889, p < 0.001), but not with ALT levels and liver stiffness. The correlation between HCV RNA and HCVcAg was particularly high in coinfected patients and those with high viremia. Mean log10 HCVcAg concentration was significantly higher in coinfected patients than in monoinfected patients. Patients harboring the TT/TT genotype of ss469415590 had significantly higher levels of log10 HCVcAg than those with the non-TT/TT genotype. HCVcAg levels were similar across HCV genotypes.
Conclusions:
HCVcAg concentrations had an excellent correlation with HCV RNA levels, particularly in HCV/HIV-coinfected individuals and might be associated with IFNL4 polymorphism. HCVcAg testing could be used as an alternative to HCV RNA assays in resource-limited settings.
More Related Videos
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction

